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Abstract:
Recently, the Kim Lab has shown that the cystic fibrosis transmembrane
conductance regulator (cftr) gene is responsible for mediating resistance to Pseudomonas
aeruginosa in a zebrafish infection model. Using the Gene Expression Omnibus, an
NCBI functional genomics data repository, it was determined that Smad3, a transcription
factor in the TGF-β signaling pathway, is upregulated in the presence of P. aeruginosa. It
was found that in our zebrafish model, the Smad3 paralogs Smad3a and Smad3b are
upregulated following microinjection of a cftr antisense morpholino oligomer. It was also
found that microinjection of Smad3a and Smad3b morpholinos, along with a Smad2
morpholino, and subsequent infection with Pseudomonas aeruginosa resulted in an
increase in death, indicating that Smad3 has a protective effect against infection.
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THESIS INTRODUCTION:
The goal of this thesis is to further investigate and characterize cystic fibrosis
(CF), an autosomal recessive multi-organ disease that is the result of a mutation in the
cftr gene. The cftr mutation results in a nonfunctional form of a chloride channel that is
essential for maintaining an ion balance within multiple organs. As a result of this cftrrelated imbalance, many functional problems can occur in these organs. A characteristic
condition in patients with cystic fibrosis is thick mucus in the respiratory tract that
becomes prime breeding ground for bacteria (12, 18, 27).
The cftr mutation also affects the innate immune system, the part of the immune
system that is the first to respond to infection. Because of this deleterious effect on the
innate immune system, patients with cystic fibrosis are especially susceptible to bacterial
infection. A pathogen that exhibits unusually high levels of infectivity in cystic fibrosis is
Pseudomonas aeruginosa, a bacterium that is able to colonize the mucus of cystic fibrosis
patients due to its anti-phagocytic activity and resistance to antimicrobials (12, 22).
Further characterization of cftr is necessary in order to determine why it is only
Pseudomonas aeruginosa that exhibits this high level of bacterial burden.
We are interested in characterizing some of the other genes that are also affected
by this cftr mutation. The Kim Lab is involved in a collaborative effort to retrieve a list of
candidate genes that are affected by the cftr mutation, Pseudomonas aeruginosa
infection, and arsenic exposure. Since these data are not yet available, previously
published data was used to investigate the link between the cftr mutation and
Pseudomonas aeruginosa infection. While amassing my own list of candidate genes, I

2
identified Smad3, a transcription factor that is instrumental in regulating genes in the
TGF-β signaling pathway, as a possible candidate gene. I wanted to investigate how the
cystic fibrosis condition or bacterial infection could play a role in the expression levels of
Smad3. Conversely, I wanted to investigate the effects of knocking down Smad3 in
conjunction with a Pseudomonas aeruginosa infection.

LITERATURE REVIEW:
Danio rerio as a model organism
The zebrafish, Danio rerio, is a freshwater fish that has become increasingly
exploited as a model organism. The development of zebrafish as a model organism began
in the 1970s, when George Streisinger was looking for a vertebrate model to study the
development of the nervous system, as well as to examine mutation-based genetic
analysis. Zebrafish have a low cost of maintenance, ease of maintenance, and have large
clutch sizes (11).
The genome of Danio rerio has been sequenced and has a high degree of gene
similarity to Homo sapiens (6). Due to this similarity, human diseases like cystic fibrosis,
muscular dystrophy, and several types of organ diseases, can be studied in the zebrafish
model. Zebrafish has particular usefulness as a model organism in the studies of the
innate immune system because it takes the zebrafish about 4 weeks to develop an
adaptive immune system. Therefore, it is possible to look exclusively at the innate
immune system (6, 32). Another advantage of the zebrafish as a model organism is its
ability to be genetically modified in order to display certain characteristics, such as GFP-
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tagged neutrophils. Antisense RNA technologies like morpholino oligomers are also used
in the zebrafish model, in which a loss of function effect can be produced either by
knocking down translation or blocking the splicing of the mRNA (34).
Zebrafish are useful for infection models like Pseudomonas aeruginosa, where
both localized and systemic infections can be observed. One of the most defining features
of using the zebrafish as a model for bacterial infection is its optical clarity, and the
ability to look at infection real-time. Its optical clarity is important for certain injections,
including into the Duct of Cuvier and into the hindbrain. Real-time analysis pertains to
the idea that during the first week post fertilization, infections can be visualized in situ
using fluorescent proteins on the bacterium (35).

Cystic Fibrosis and the cftr gene
Cystic fibrosis is among the most common genetically inherited diseases in the
world, primarily affecting those of European descent. It is the most common lethal
autosomal recessive disease in the white population, and affects about 1 in 3500
Americans (27). Cystic fibrosis is caused by a mutation in the cystic fibrosis
transmembrane conductance regulator (cftr) gene, which codes for the CFTR protein, a
chloride channel that resides in the cell membrane of epithelial cells. The most common
change to this gene is F508del, a deletion of the nucleotides CTT in the gene, causing the
loss of phenylalanine from the protein (27). There are a number of other mutations that
can lead to cystic fibrosis, and some appear to be more prevalent in different populations.
Due to the deletion of phenylalanine, the protein will misfold and be targeted for
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degradation by the ubiquitin-proteasome pathway. Therefore, it will never reach the cell
membrane (36). Other mutations of cftr can result in the protein reaching the cell
membrane, but it will not be entirely functional (1, 3).
The CFTR protein is a chloride channel that is present in epithelial cells and is
responsible for the conductance of chloride in and out of these cells (Figure 1). CFTR is a
member of the ATP binding cassette protein family, in which the defining characteristics
of this family are two membrane spanning helices and two nucleotide binding domains.
The phenylalanine deletion in cftr occurs in the region of the gene corresponding to
nucleotide binding domain one (NBD1). CFTR also contains a regulatory domain,
making it unique among the ABC proteins (15). When unphosphorylated, the regulatory
domain has a disordered shape, and prevents dimerization of NBD1 and NBD2, an action
that is necessary to open the channel. When phosphorylated, the R domain assumes a
more orderly structure, and allows for dimerization of NBD1 and NBD2 (2).
Phosphorylation of these dimerized domains allows for the passing of chloride through
the channel.
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Figure 1. The CFTR channel as it is shown in an epithelial cell membrane.
Phosphorylation of the R domain, NBD1, and NBD2 are all required in order to open the
channel for chloride passage.
The CFTR protein is present in epithelial cells such as lung, liver, pancreas, and
skin cells. The F508del mutation has a devastating effect on airway epithelial cells, where
if it is not present to transport chloride across the cell membranes, a sodium-chloride ion
imbalance results (33). This imbalance also affects the water content in these airways,
affecting airway surface liquid, mucus transport, and will also result in thick mucus as a
result of mucus dehydration. Thick mucus clogging the airways is one of the most
common characteristics of cystic fibrosis, and it is very difficult for the cilia of these
epithelial cells to clear this mucus from the airways. This mucus becomes an optimum
media for pathogens like Pesudomonas aeruginosa to inhabit and colonize. Constant
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infection and inflammation can lead to complications like pneumothorax, hypertension,
and eventually death (18).
Currently, there is no cure for cystic fibrosis, but treatments and therapies are
available to help lessen the complications that come with the disease. There are drugs
available, such as Kalydeco TM that can help people with the G551D mutation in the cftr
gene. In this condition, the protein is transported to the membrane, but does not function.
This drug helps to activate the NBDs and R domain to allow chloride transport. There are
ongoing clinical trials with other drugs to investigate a treatment for F508del. Other
treatments and therapies include antibiotics, chest physiotherapy, and mucus thinners (9).

Pseudomonas aeruginosa
Pseudomonas aeruginosa is an opportunistic pathogen that is particularly invasive
and problematic in patients with cystic fibrosis. It is a Gram-negative bacterium, with a
membrane that has very low permeability, allowing it to have exceptional resistance to
many antimicrobial drugs. Pseudomonas aeruginosa has the ability to secrete virulence
factors via the Type III secretion system, where it relies on contact with epithelial cells.
Such virulence factors lead to altered immune responses and cell death (8).
Pseudomonas aeruginosa has a limited number of porins, as well as a number of
secondary mechanisms to prevent death of the cell. Secondary mechanisms, such as βlactamase production and overexpression of efflux pumps, combine with the low
permeability of the membrane to ensure that antibiotics are unable to act upon the
organism. Also, mutations can lead to either increased resistance or increased
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susceptibility to these antibiotics, although typically such mutations would lead to
something like the overexpression of efflux pumps and reduced uptake (4). In addition to
mutations, horizontal gene transfer via transposons and plasmids will also confer
additional resistance to Pseudomonas aeruginosa populations. In these gene transfers,
targets of antibiotics will usually be modified slightly in order for them to be
unrecognizable by the antibiotics (4, 8).
In patients with cystic fibrosis, the link between antibiotic resistance and
virulence often leads to respiratory failure and lethal complications. A hallmark
characteristic of Pseudomonas aeruginosa is the formation of biofilms, in which a
congregation of cells grows to create a community of antibiotic resistance, as well as
increased resistance to the natural immune system mechanisms from the host. One of the
most important aspects for chronic Pseudomonas aeruginosa infection is its ability to
switch classes, from the biofilm, or mucoid, form of growth to the nonmucoid form of
growth (Table 1). Each class has its own specific advantages, ranging from antiphagocytic activity to antimicrobial resistance. (8, 12)

Table 1. The above table shows the advantages between each phenotype, and how
it is particularly advantageous to switch between these phenotypes.
In the cystic fibrosis condition, airway mucus becomes thicker and is harder to
clear from the airways by cilia. This mucus becomes an ideal colonization medium for
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Pseudomonas aeruginosa. The formation of biofilms in patients with cystic fibrosis in
this mucus exacerbates inflammation and airway blockage, causing respiratory damage
Chronic inhabitation of these airways by the bacteria results in an overzealous neutrophil
response, leading to an increase in respiratory tract damage. Constant infection results in
the activation of pro-inflammatory cytokines, such as IL-8, and other pro-inflammatory
elements, such as ICAM-1. Neutrophil elastase is directly responsible for damaging the
airway wall by degrading elastin. Reactive oxygen species and defensins are meant to
help clear the infection, but end up being contributors to the scarring of the lung tissue.
Respiratory failure eventually results due to constant infection (7, 33).

The Innate Immune System
The immune system is a collection of different types and systems that are in
cooperation to ward off infections by bacteria and viruses. It can be broken up into the
innate and adaptive immune systems, where innate immunity is primarily composed of
non-memory related cells, while adaptive immunity has the capability to recognize a
returning pathogen or infection, and a quicker, more specific defense can be launched
(Table 2) (21).
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Response Time
Specificity

Innate Immunity
Physical and Chemical
Barriers
Phagocytic leukocytes
Dendritic Cells
NK Cells
Immediate
General

Memory

No

Components and Cells
Involved

Adaptive Immunity
Cell Mediated Immunity via
T Cells
Humoral Immunity via B
Cells
Much slower (days)
Very specific to certain
antigens
Yes – memory B Cells
have the ability to
“remember” previous
antigens

Table 2. The comparisons between innate and adaptive immunity (21, 23).

Although the innate immune system is not more specific than the adaptive system,
it does provide the first line of defense for the body. This line of defense comes primarily
in the form of mast cells, macrophages, neutrophils, natural killer cells, and dendritic
cells (23). Each of these types of cells can perform different functions, whether it is
phagocytosis, the release of certain inflammatory cytokines, or the recruitment of other
members of the immune system. Together, the cells of the innate immune system are able
to form a comprehensive first line of defense, while the more specific adaptive immune
system is given time to react.
Some of the first responders to a site of infection are the neutrophils, which act to
defend the body by phagocytosis and the release of various cytokines and granules (7,
33). The way in which neutrophils and other macrophages differ is through the presence
of granules in neutrophils, which contain various enzymes like lysozyme,
myeloperoxidase, and NADPH oxidase (21, 23). Neutrophils and macrophages are able
to recognize their targets to be phagocytized is by the utilization of pattern recognition
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receptors (PRRs). PRRs recognize and bind to pathogen-associated molecular patterns,
PAMPs. Common PRRs include the Toll-like receptors (TLRs), mannose receptors,
CD14, which is primarily found on macrophages, and NOD-like receptors, among others
(21).
The TLR family of receptors contains multiple members, all of which are capable
of recognizing different bacterial of virus components (Figure 2). TLRs are
transmembrane receptors that contain a leucine rich repeat domain responsible for
recognition of PAMPs, as well as an intracellular domain that is responsible for signal
transduction. Some of the molecules that are recognized by TLRs include flagellin,
lipopolysaccharide, ssDNA, and peptidoglvcan (21). Toll-like receptor 4 is responsible
for recognizing lipid A, a component of the cell wall of Pseudomonas aeruginosa.
Recognition of this lipid results in a pro-inflammatory response, which includes the
release of various cytokines and chemokines that can increase blood flow, induce
proliferation of immune cells, and recruit neutrophils to the site of infection (5, 10). Tolllike receptor 5 is another TLR responsible for the recognition of Pseudomonas
aeruginosa. TLR5 is able to identify flagellin, the subunit that makes up the flagellum of
Psuedomonas aeruginosa (22, 30).
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Figure 2. Shown are mammalian TLRs with known ligands, represented as they would be
displayed on the cell surface (30).
In response to a component like LPS or other bacterial-specific molecules, a
series of inflammatory events occur in order to reduce the potential hazardous effects of
the pathogen. In particular, IL-1, IL-6, IL-18, IL-12, and TNFα can all work together to
increase the inflammatory response. Such a response would increase body temperature
thereby reducing the capability of the pathogen to replicate, as well as increase the
migration of neutrophils and other macrophages to the site of infection via chemotaxis
(21).

TGF-Beta Signaling Pathway
The transforming growth factor beta, or TGF-β, signaling pathway is an integral
part of cell signaling within the cell. The TGF-β pathway is host to a number of different
functions through ligand-activation of receptors on the cell membrane, phosphorylation
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of transcription factors called Smads, and shuttling of these Smad transcription factors to
the nucleus to regulate gene transcription (Figure 3). Among the notable functions of the
TGF-β signaling pathway are regulation of the cell cycle and apoptosis, as well as
immunosuppression and inflammatory and anti-inflammatory cytokine regulation (13, 14,
25, 26).

Figure 3. An overview of the TGF-β pathway. The binding of ligands to their
appropriate receptor results in phosphorylation of Smad transcription factors. These
transcription factors are shuttled to the nucleus, where they bind target DNA and result in
the transcription of that gene (13).
The pathway begins with the binding of a ligand to the TGF-β receptors found on
the cell membrane. These ligands consist of two different families: the TGFβ/Activin/Nodal family of ligands and the BMP/GDS/MIS family of ligands. Although
each family, and each ligand itself, elicits a different response, they are characterized by
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6 cysteine residues within the ligand. The role of these cysteine residues is to form
intramolecular and intermolecular disulfide bridges. All of the TGF-β ligands exist in a
pro-peptide form that is cleaved into the mature form. The function of the pro-peptide can
vary between the different ligands, but primarily, it exists to serves as a scaffolding
protein. It can also play a role in ligand stability (25). These ligands are shuttled to the
cell membrane of target cells, where TGF-β receptors await to receive and transduce the
message.
There are two different families of TGF-β receptors, the type I receptors and type
II receptors. The BMP family of ligands shows high specificity for type I recptors, and
low specificity for type II, while the TGF-β family typically only interacts with type II
(31). The receptors are made up of an extracellular N-terminus domain, which binds the
ligand, a transmembrane domain, and an intracellular C-terminus domain. Unique ligand
binding domains on the surface of type I and type II receptors ensure that the proper
ligands are bound to the right receptor. BMP homodimers interact with their type I
receptor via hydrophobic interactions. TGF-β ligands also form homodimers, forming
large receptor complexes with type II receptors, followed by complexing with type I
receptors (31).
Upon binding of TGF-β ligands to the type II receptor, an interaction between
type I and type II receptors occurs (Figure 4). A key structural difference between the
two types of receptors is that the type I receptor contains a glycine-serine (GS) domain at
its C-terminus, which is important for the type I/type II receptor interaction. Type II
receptors contain a serine/threonine kinase domain at their C-terminus, which targets
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serine and threonine residues in the C-terminus of type I receptors, specifically the
TTSGSGSG sequences in this domain (26, 31).

Figure 4. The TGF-β ligand (blue and cyan) forms a homodimer that initially
binds to the type II receptor ligand binding ectodomain (yellow). Then, it is able to also
bind to the type I receptor (purple), forming the large receptor complex. The binding and
proximity of the type I and type II receptors allows for phosphorylation and signal
transduction (31).
A phosphorylated type I receptor also acts as a kinase, phosphorylating
transcription factors called Smads. In humans, there are 8 Smad proteins, belonging to 3
different families, consisting of receptor-activated Smads 1, 2, 3, 5 and 8, co-Smad4, and
inhibitory Smad7 (26). Structurally, Smad proteins have 2 conserved domains. The MH1
domain is the N-terminal domain, and is primarily responsible for sequence-specific
DNA recognition. The MH2 domain, at the C-terminus, directly interacts with nuclear
pores, allowing access into the nucleus. It also regulates oligomerisation with other
Smads (26). An SxS motif in the MH2 domain is critical for receptor recognition.
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Phosphorylation of this domain by the type I receptor is required for Smads to be
translocated to the nucleus. Disruption of this motif would result in altered levels of
Smad signaling (26).
R-Smads are recognized by the type I receptor kinase by two structural
characteristics. A basic patch of amino acids on the surface of R-Smads allows for
binding of the phosphorylated GS domain on the type I receptor to Smad (26). The
specificity of binding results from the interaction between the L45 loop of the type I
receptor and the L3 loop of R-Smads (31). As a result, TGF-β receptors only recognize
Smad2 and Smad3, while BMP receptors recognize Smad1, Smad5, and Smad8. The
specificity within the receptors comes down to matching sets of receptor loop L45 and
Smad loop L3. Smads can be localized at the cell membrane next to TGF-β receptors by
the Smad anchor for receptor activation, SARA. SARA binds to Smad2 or Smad3 via a
hydrophobic surface region (31).
Once localized to the membrane, Smad is ready to be phosphorylated by TGFβR1. Phosphorylation of the SxS motif in the MH2 domain of R-Smads results in
dissociation from SARA. This phosphorylated motif is then able to interact with other
Smad proteins, either forming homomers or heteromers. Smad3 will also associate with
Smad4, the co-Smad, in order to assist with translocatation to the nucleus (37). All of the
Smads contain their own nuclear localization sequences, which are able to bind to
specific importin proteins that transport them into the nucleus (26).
With the R-Smad in the nucleus, it is nearly ready to promote transcription of its
target gene. Smads bind to DNA with sequence specificity. The Smad binding element,
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located on the target DNA sequence, at minimum, requires the sequence 5’AGAC 3’, but
will typically be recognized by Smad with additional bases on either end (Figure 5). RSmads achieve specific target DNA binding due to cell-type specific cofactors, including
co-activators and co-repressors, as well as other Smads and DNA binding elements. The
association of Smad to an array of molecules results in the transcription of specific genes
(25).

Figure 5. A simplified diagram of Smad3 associating with Smad4 and other cofactors,
binding to its target sequence in the promoter region. This gene would have transcription
machinery recruited to it.
In short, Smad3, and all transcription factors, facilitate transcription of these
target genes by binding to their target sequence in the promoter region of the target
segment of DNA. Essentially, this will either promote or repress transcription of these
genes by stabilizing or destabilizing the DNA, affecting the way in which RNA
polymerase is able to bind to the DNA. In the case of Smad3, binding to its target gene
will actively recruit transcription machinery to the target, resulting in the transcription
and eventual translation of the gene.
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Smad signaling can be either positively or negatively regulated through direct
competition for binding sites, as well as through the ubiquitin-dependent degradation
pathway. The direct competition for binding sites on TGFβ receptors, R-Smads or coSmad4, is achieved via binding by c-Ski, Smad6, or Smad7 (19). C-Ski negatively
regulates Smad signaling by competing for the MH2 domain on Smad4. When
interfering, a complete Smad complex is unable to form, and as a result, the transduction
from the receptor is unable to continue. I-Smad7 does not directly interfere with any of
the R-Smads, but instead acts by binding to TGFβR1, and in the process, inhibits
phosphorylation of the R-Smads. Smad6 is able to bind to R-Smads, preventing the
formation of a complete complex, similar to c-Ski (31).
Another method of inhibition is through a variety of ubiquitin-dependent
degradation pathways, including the E3 ubiquitin ligases Smurf and APC. These ligases
have target proteins that associate with the Smads, which can include c-Ski and SnoN.
SnoN is able to activate the ubiquitin-mediated pathway of degradation by associating
with the Smad that is to be degraded. SnoN can either downregulate or upregulate the
pathway, depending on which Smad it binds to. It recruits Smurf1 and Smurf2, which are
Smad ubiquitin regulatory factors. These Smurfs induce degradation of R-Smads by the
ubiquitin-proteasome pathway (13).
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Targets of Smad3, the Immune System, and the Connection to Cystic Fibrosis
With the complexity and vastness of the TGF-β pathway being as large and
encompassing as it is, it is no surprise that there are many targets of Smad3. Although
targets of Smad3 and the TGF-β pathway usually play a role in cell cycle, apoptosis, or
cytoskeleton rearrangement, there are still targets that can play either a direct or indirect
role in the immune system. Among the most important targets of Smad3 in relation to the
immune system are the anti-inflammatory cytokines IL-10 and RANTES, and the
inflammatory cytokine IL-8 (14, 17, 19, 28). In normal lung epithelial tissue, the presence
of TGFβ1 as a ligand and Smad3 would result in the upregulation of RANTES and
downregulation of IL-8. The IL-8 promoter is Smad3-repressible; that is, when Smad3 is
present, IL-8 will not be transcribed (17). But, previous studies have shown that the
cystic fibrosis condition results in the knockdown of Smad3 in nasal epithelium. As a
result, the anti-inflammatory cytokines for which it is responsible for regulating, IL-10
and RANTES, are downregulated, and since Smad3 is not present, IL-8 is able to be
transcribed, resulting in an increased inflammatory condition (17).
Smad3 was found to target the gene responsible for encoding MARCKS, a protein
that is responsible for actin rearrangement. This actin rearrangement helps to guide
neutrophils to the site of infection (38). Since Smad3 appears to be knocked-down in
cystic fibrosis-affected nasal epithelial tissue, MARCKS would also be affected, lowering
the rate at which neutrophils are able to migrate to the infection site. This would
potentially decrease the overall ability of the immune system to clear the airways of
pathogens like Pseudomonas aeruginosa. The importance of Smad3 in relation to the
cystic fibrosis condition remains to be seen. But, altered levels of Smad3 would most
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certainly affect its immune targets, thereby affecting the organism’s ability to handle and
clear an infection.

INTRODUCTION
Cystic fibrosis is the most common autosomal recessive disorder in North
America, affecting 1 in 3500 Americans (27). Under normal conditions, the cystic
fibrosis transmembrane conductance regulator (CFTR) is responsible for chloride ion
transport, and is found in the membranes of epithelial cells. In patients with cystic
fibrosis, a mutation in the cftr gene exists. There are a multitude of mutations that can
result in varying degrees of the disease, but the most common mutation is the F508
deletion, in which the phenylalanine residue at position 508 is deleted. The F508 deletion
that occurs in nucleotide binding domain 1 of CFTR results in the misfolding of the
protein, and due to this mutation, the protein will never reach the plasma membrane. As a
result of the mutation, chloride ion transport across these epithelial cell membranes is
severely affected. It also indirectly affects sodium ion transport, as well as water balance
(7, 24, 27).
A characteristic condition resulting from the F508 deletion is thick and dry mucus
due to the overall ion and water imbalance. This mucus becomes optimum breeding
ground for many types of pathogens, particularly Pseudomonas aeruginosa (5, 29).
Pseudomonas aeruginosa is problematic for patients with cystic fibrosis due to the
bacterium’s low membrane permeability, as well as its ability switch back and forth
between multiple forms. Its low membrane permeability allows for increased resistance
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to antibiotics, and its ability to switch between nonmucoid and mucoid forms allows for
phagocytic resistance. In those with the cftr mutation, Pseudomonas aeruginosa is the
pathogen that has been reported to have the highest bacterial burden (29). It is not entirely
known why the cftr mutation causes increased susceptibility to Pseudomonas aeruginosa
and not other bacteria.
In response to infection by Pseudomonas aeruginosa, the immune system
responds with the migration of neutrophils. Neutrophils are granulocytic phagocytes that
will release various degradative proteins in response to the infection. Such degradative
proteins include elastase and lysozyme (22, 24). An overzealous immune response by
these neutrophils results in scarring and inflammation in the lungs of cystic fibrosis
patients. To help with the migration of neutrophils are various chemokines that can be
released by cells that have come in contact with a foreign antigen (21). The regulation of
some of these chemokines can be traced to the TGF-β signaling pathway. Although this
pathway is more notorious for regulating process like cellular differentiation, apoptosis,
and the cell cycle, some of its targets are immune related (13, 17).
A key part of the TGF-β pathway is Smad3, a transcription factor that is
translocated to the nucleus and is responsible for binding to the promoter region of genes
to be regulated. The immune-related targets of Smad3 include IL-10, an antiinflammatory cytokine, and MARCKS, a protein that is responsible for actin cytoskeleton
rearrangement to assist with neutrophil migration. Previous research has shown that the
expression levels of Smad3 are altered in response to a knockdown of cftr¸ specifically in
nasal epithelium (17). We are interested in whether Smad3 could play a protective role in
defense against infection, and what its role in connection to cftr could be.
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METHODS
Identification of Novel Gene Targets using NCBI’s Gene Expression Omnibus
Gene targets for characterization were identified using multiple databases through
NCBI’s Gene Expression Omnibus tool. The databases selected for analysis and gene
selection were: Bronchial epithelial cell line response to various airway pathogens
(GDS2606), Airway epithelial cell response to Pseudomonas aeruginosa rsmA mutant
infection (GDS2287), Cystic fibrosis patients with mild and severe lung disease: nasal
respiratory epithelium (GDS2143), Cystic fibrosis and small intestine (GDS588) and
Cystic fibrosis pancreatic gene expression (GDS567). Genes were selected based on their
upregulation either in the presence of Pseudomonas aeruginosa infection or the presence
of cystic fibrosis, depending on the database.

Zebrafish Maintenance
Zebrafish embryos were maintained in 50 mL of egg water (60 mg/L of Instant
Ocean, Spectrum Brands, Madison, WI). Embryos were maintained at 28° C.

Antisense Morpholino Injections
Antisense morpholino oligonucleotide injections were performed on zebrafish
embryos that were currently in the 1 cell stage (0.5-1 hpf). Cftr morpholino injections
were performed with 3 nl, at 2.5 ng per embryo. Two different morpholinos were used: a
splice blocker morpholino and translation blocker morpholino, as designed by Phennicie
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et al (Table 3) (29) . Smad3a and Smad3b morpholinos were co-injected at 2 ng per
embryo, along with a p53 morpholino at 12.5 ng, for a total injection volume of 3 nl.
When performing Smad2, Smad3a, and Smad3b morpholino injections, 2 ng per embryo
was once again used, with 18.75 ng of p53 per embryo. Smad2, Smad3a, and Smad3b
morpholinos were designed by Jia et al (16).
Gene Name
Cftr (Translation blocker)
Cftr (Splice blocker)
Smad3a
Smad3b

Morpholino Sequence
5′-CCACCTGTAAATATTCAGAGCAGAT-3′
5′-CATCCTCCACAGGTGATCTCTGCAT-3′
5’-TTCAGTTCAGCGTTCCTCTATTGC-3’
5’-GCAATATAGACATCTTTAGTTGAT-3’

Table 3. Morpholino antisense oligonucleotide design for 1 cell injections, as synthesized
by Gene Tools (Philomath, OR).

Bacterial Injections
Wild-type Pseudomonas aeruginosa PA14 was grown overnight in LB broth at
37° C. Liquid cultures were washed with phosphate-buffered saline, and cell density was
determined using a spectrophotometer. Pseudomonas aeruginosa and PBS injections
were performed 2 days post morpholino injection. To ensure a systemic infection,
injections took place in the Duct of Cuvier. An injection volume of 3 nl was used for 250
CFU and 1 nl for 150 and 90 CFU.
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RNA Extraction and cDNA Synthesis
RNA extraction was performed using the TRIzol phenol/chloroform extraction
method (Invitrogen). RNA extractions were done in triplicate, with 10 fish in each
replicate. Fish were homogenized into the TRIzol reagent, which was followed by an
incubation period of 3 min. with chloroform and centrifugation at 4° C for 15 min. at
12000 g. RNA was isolated by adding 250 x linear acrylamide and 100% isopropanol to
the aqueous phase, which was centrifuged at 15000 x g for 15 min. at 4° C. The RNA
pellet was washed with 70% ethanol, spun at 15000 g for 5 min. and 4° C. The RNA
pellet was resuspended into RNAse-free 10mM Tris-Cl, pH 8.0, and incubated at 50° C
for 15 min. Extracted RNA was converted to cDNA using the iScript cDNA synthesis kit
(BioRad, Hercules, CA).

Quantitative PCR
Target gene primers were designed using Primer3 for quantitative PCR (Table 4).
Fold induction values were determined using a CFX96 real-time detection system with
cDNA synthesized from control morpholino and cftr morpholino injected embryos and
SsoFast EvaGreen as the fluorescent dye for detection of expression (BioRad, Hercules,
CA).
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Gene name
Smad3a
Smad3b
Vrk3

Ptpn2a
Ptpn2b

Forward Primer (5’-3’)
GCA ACT ACA TAC CAG
AGA CGC C
TGG ACA CAG GTT CTC
CAA CG
TGA ACC TTC ACC GCA
ACA AG

Reverse Primer (5’-3’)
TGG AGA ACC TGT GTC
CAT GC
TGG TTG TGA GGC ATG
GAA AG
GAG GAG TCC CCA
GCA CAA TC

TGG AGG AGG CTC
AAA GAA GG
CTG GTT GAC ACT TGT
CTT GTC TTG

TTG GAA CCC TGT TCC
CAA AC
TCT CGC CAT TGT TTC
TGC AC

Table 4. List of primers designed for quantitative PCR.

Cloning of Smad3a and Smad3b
Smad3a and Smad3b were cloned using the following primers: Smad3a:
CGTGAGAGACTGCGCAATAG (forward) and TACATTGGGCCAGATTTGTG
(reverse). Smad3b was cloned using heminested primers, which comprised of:
ATCATGCGGTGATGTGACTC (forward), GAGTCCAGAGGCTGTTTTGC (reverse,
outside) and TGAGTGAGCACCTTGTCCAG (reverse, inside). cDNA was used from
uninjected zebrafish. Desired genes were inserted into TOPO TA vectors (Invitrogen,
Carlsbad, CA) and transformed into NEB competent cells (New England Biolabs,
Ipswich, MA).
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RESULTS
Upregulation of Smad3a/Smad3b in cftr Morpholino Injected Whole Fish Tissue
We wanted to investigate the effects that the cftr knockdown would have on the
expression of our target genes. Quantitative PCR was performed using zebrafish that had
been injected with the cftr morpholino. Analysis of gene expression in this whole fish
tissue indicates that both Smad3a and Smad3b are upregulated in fish with lower
expression levels of cftr (Figure 6). Smad3a shows a 1.36 fold induction, while Smad3b
shows a 1.52 fold induction.

Fold Induction of Target Genes
2
1.5

Fold Induction

1
Ptpn2a

0.5

Ptpn2b
0

Vrk3

-0.5

Smad3a

-1

Smad3b

-1.5
-2

Gene Names

Figure 6. Quantitative PCR graphs of cftr morpholino injected fish. The activity of target
genes in cftr morpholino injected fish was measured in comparison to injection with a
control morpholino. All samples were normalized to beta-actin levels of expression.
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Increased Death Associated with cftr Morpholino Injection in Conjunction with
Pseudomonas aeruginosa Infection
Phennicie et. al had previously performed bacterial burden studies with
Pseudomonas aeruginosa using cftr morpholino injected fish. They had shown that the
bacterial burden is higher in fish with the cftr knockdown (29). A mortality curve had not
been published, so we aimed to produce a curve showing that this increased bacterial
burden would correspond to an increase in death over control. An increase in death has
been shown, consistent with the previous research suggesting that cftr knockdown has a
negative-regulatory effect on the immune system (Figure 7).

Effect of cftr MO on mortality of
Pseudomonas aeruginosa infected fish

Percent survival

100

Control PBS (N=32)
cftr MO PBS (N=50)
Control PA (N=23)
cftr MO PA (N=17)

80
60
40
20
0
0

1

2

3

4

Days

Figure 7. cftr knockdown and associated death in conjunction with Pseudomonas
aeruginosa infection. Phennicie et al. had previously proven an increase in bacterial
burden existed in fish with the cftr morpholino. Here it is shown that there is an increase
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in death in morpholino injected fish with the infection at 150 CFU (unpublished data
from Sullivan). Although there appears to be an increase in death, the P-value, as
calculated by the Logrank test, is 0.1553, indicating there is this trend of death is not
statistically significant.

Increased Death Associated with Smad3a/Smad3b Morpholino Injected Fish along
with Pseudomonas aeruginosa Infection
Morpholinos of Smad3a and Smad3b were used to attempt to see if these genes
had a role in survival of the fish upon infection with Pseudomonas aeruginosa. Embryos
were also co-injected with a p53 morpholino to ensure that off-target effects of the
Smad3a/3b morpholinos were not induced. After 1 day of infection, there was a 13%
increase in death among the Smad3a/3b morpholino injected fish in comparison to
control fish (Figure 8). Further experiments need to be performed in order to more
accurately determine if there is a significant increase in death of these fish due to the
morpholino knockdown, and not just due to infection.
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Effect of Smad3a/3b MO on mortality of
Pseudomonas aeruginosa infected fish

Percent survival
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Figure 8.The percent survival of morpholino and Pseudomonas aeruginosa injected fish
with 250 CFU. Shown is the apparent increase in death after 1 day of infection, indicating
that in the very short term, Smad3a and Smad3b knockdown may contribute to the
increased death of the fish. This trend of increased death was proved to be insignificant,
as calculated by the Logrank test, resulting in a P-value of 0.5214.
We believe there to be a functional redundancy between Smad3 and Smad2,
another transcription factor with similar roles in the TGF-β pathway. Another set of
injections was performed, this time with the Smad2 morpholino included (Figure 9).
These injections resulted in a 20% increase in death in morpholino injected fish after day
1 and day 2 post infection.
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Effect of Smad2/3a/3b MO on mortality of
Pseudomonas aeruginosa infected fish

Percent survival
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Figure 9. The percent survival of fish also injected with the Smad2 morpholino, at 90
CFU. In this graph, both the functional redundancy and amount of bacteria injected have
been accounted for from the previous injection, resulting in a widened gap between
control and morpholino injected fish. This trend was proved to be insignificant, as
calculated by the Logrnak test, resulting in a P-value of 0.988.

Identification of Smad3 Target Genes
Smad3 target genes were identified using GEO, in which regulated genes specific
to the immune system were identified (Table 5) (38). Although this is not an exhaustive
list of target genes, analysis of these selected genes via qPCR will be performed to
determine their levels of expression in cftr morpholino injected fish or Pseudomonas
aeruginosa infected fish.
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Gene
TACR1
WASPIP
Wdr34

PREP
YWHAZ
TCF7
MARCKS
OPN3

Function
Substance P binding, control of innate
immunity
Responsiveness to IL-2
TAK1-associated suppressor of the IL1R/TLR3/TLR4-induced NF-kappaB activation
pathway
Regulation of IL-10
Role in phagocytosis and microbial resistance
(Transcription factor 7 / T Cell Factor 1)Wnt
pathway, regulation of expression of IL-17
Regulation of neutrophil migration
Possible role in airway inflammation

Table 5. A selective list of Smad3 target genes, as identified in “SMAD3 targets
in A549 lung epithelial cells, GSE26858” (38).

DISCUSSION
Use of Bioinformatics to Determine Gene Targets
This study began with the analysis of various databases that contained gene
expression data from various experimental conditions. By cross-referencing these
databases and conducting further literature review, a selective list of target genes was
created to investigate further (Table 4). The use of bioinformatics, microarrays and deep
sequencing data is quickly becoming the most efficient method to look at gene expression
on a large scale. The Kim Lab is currently in the middle of a collaborative effort to
analyze gene expression from zebrafish that have been exposed to arsenic in conjunction
with cftr knockdown and Pseudomonas aeruginosa infection. Once these data are
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released, another comprehensive set of genes will be available that can offer further
insight into the cystic fibrosis condition.

Activity and Targets of Smad3
We have found that expression levels of both Smad3 paralogs are upregulated in
whole fish injected with the cftr morpholinos (Figure 6). It is also worth noting that
Smad2 was found to be upregulated in the same database that Smad3 was identified from,
further strengthening our theory of a functional redundancy. Based on these data, and
with the knowledge that Smad3 has potential to regulate inflammatory and antiinflammatory responses, the increase in expression of Smad3 could be due to the need for
more anti-inflammatory cytokines. IL-10, an anti-inflammatory target of Smad3 could be
expressed to prevent an overzealous inflammatory reaction by the rest of the immune
system (17). MARCKS, an actin rearranging protein, may also be upregulated to help
with the migration of neutrophils to the site of infection (38).
Previous research suggests that, in nasal epithelium with the expression of cftr
knocked-down, Smad3 also is knocked down (17). It should follow that the previous antiinflammatory response described above would not occur in nasal epithelium tissues with
the cftr knockdown. Instead, an increase in IL-8, an inflammatory cytokine, was observed
in these tissues. The knockdown of cftr, and therefore Smad3, could play a role in
exacerbating the inflammatory response in patients with cystic fibrosis by increasing the
levels of IL-8 produced and decreasing the levels of IL-10 produced.
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By recognizing that Smad3 has differential expression due to the cftr knockdown,
it will be worthwhile to work with the targets of Smad3 to attempt to determine if these
targets are also differentially expressed (Table 5). With the knowledge that a cftr
knockdown also results in an increase in death, it is possible that the differential
expression of these targets could contribute to this death.

Using a Tetracycline Inducible Promoter to Examine Spatial and Temporal
Expression
In order to examine organ specific expression of Smad3 in zebrafish, tetracyclineinducible promoter system will be utilized. Thanks to the Weidinger Lab, (Biotechnology
Center and Center for Regenerative Therapies, Dresden, Germany) plasmids have been
obtained containing promoters with the capability of being turned on and off in the
presence or absence of tetracycline (20). A cftr promoter will be used in this plasmid to
drive the expression of a dominant negative Smad3b gene. In the dominant negative
Smad3b, the phosphorylation site that is necessary for translocation to the nucleus has
been disrupted. Therefore, only tissue that contains the cftr gene will express dominant
negative Smad3b. Desired experimental variables, such as the injection of the cftr
morpholinos and Pseudomonas aeruginosa infections, will be applied in order to see the
direct relationship between cftr and Smad3.
The cftr mutation resulting in cystic fibrosis is known to compromise the immune
system of these patients, although it has never been clearly identified how. Increased
neutrophil presence in the airways and the increase of inflammatory cytokines are
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normally signs of fighting an infection, but the vast majority of patients with cystic
fibrosis still possess compromised immune systems. Pseudomonas aeruginosa is a
bacterium that is able to take advantage of this condition, ultimately leading to death of
the host. By further characterizing cftr and the genes affected by the mutation or
Pseudomonas aeruginosa infection, it is hoped that therapies can be discovered and
introduced to develop a cure for cystic fibrosis.
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